Growth Hormone at Dr. Essa Lab

Growth Hormone at Dr. Essa Lab

The Growth Hormone at Dr. Essa Lab is a highly specialized endocrine investigation designed to measure the concentration of somatotropin (growth hormone) in the blood. Synthesized and secreted by the somatotropic cells of the anterior pituitary gland, growth hormone (GH) is a vital peptide hormone responsible for regulating linear growth, cellular reproduction, tissue regeneration, and overall metabolic homeostasis. In children, adequate levels of growth hormone are essential for normal skeletal development and stature. In adults, growth hormone plays an indispensable role in maintaining healthy bone density, muscle mass, lipid profiles, and cardiovascular function. Because growth hormone secretion is highly pulsatile and regulated by a complex feedback loop involving hypothalamic Growth Hormone-Releasing Hormone (GHRH) and somatostatin, accurate measurement requires advanced laboratory techniques and clinical expertise.

At Dr. Essa Lab, we utilize state-of-the-art diagnostic platforms, including advanced Chemiluminescence Immunoassay (CLIA) technology, to ensure the highest level of analytical sensitivity and clinical specificity. This test is crucial for diagnosing a wide range of endocrine disorders, including growth hormone deficiency (GHD), pituitary dwarfism, gigantism, and acromegaly. Because random GH levels can fluctuate dramatically throughout the day due to stress, sleep, and dietary intake, our laboratory is fully equipped to support both baseline measurements and dynamic endocrine testing, such as growth hormone stimulation and suppression tests. By choosing Dr. Essa Lab, patients and clinicians in Karachi and across Pakistan receive reliable, precise, and timely results that are essential for formulating effective treatment plans and improving patient outcomes.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical to obtaining accurate and clinically useful growth hormone measurements, as various physiological factors can transiently alter hormone levels. Patients are advised to adhere to the following preparation guidelines:

• Fasting Requirements: Patients must fast for 8 to 12 hours prior to the blood draw. Water is permitted, but all food, juices, tea, coffee, and other beverages must be avoided, as dietary intake—especially glucose—can suppress growth hormone secretion.
• Physical Rest: Avoid strenuous physical exercise or intense workouts for at least 24 hours before the test. Physical exertion is a potent physiological stimulator of growth hormone release and can lead to falsely elevated baseline results.
• Stress Reduction: Emotional and physical stress can significantly increase growth hormone levels. Patients should arrive at the laboratory early and rest quietly in a seated position for 15 to 30 minutes before the blood sample is collected.
• Medication Management: Inform your physician and the laboratory staff of all medications, vitamins, and supplements you are currently taking. Certain drugs, including corticosteroids, estrogen, levodopa, insulin, amphetamines, and beta-blockers, can interfere with growth hormone secretion. Do not stop taking any prescribed medication without consulting your doctor.
• Sleep Optimization: Ensure a normal, restful night of sleep before the test, as growth hormone release is closely linked to deep sleep cycles and circadian rhythms.

During the Procedure

The growth hormone test is a straightforward, minimally invasive blood test performed by our highly trained phlebotomists. The procedure involves the following steps:

• Patient Positioning: The patient is comfortably seated or asked to lie down in a relaxed state to minimize any anxiety or physical stress that could affect hormone levels.
• Site Selection and Cleansing: The phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm. The skin over the selected vein is thoroughly disinfected using a sterile antiseptic wipe.
• Venipuncture: A sterile, single-use needle is gently inserted into the vein. Blood is drawn into a specialized serum separator tube (SST) designed to preserve the integrity of peptide hormones.
• Dynamic Testing (If Applicable): If a growth hormone stimulation or suppression test is ordered, an intravenous (IV) cannula may be placed to allow for multiple blood draws at specific time intervals (e.g., 30, 60, 90, and 120 minutes) without the need for repeated needle sticks.
• Post-Collection Care: Once the required volume of blood is collected, the needle is carefully withdrawn, and gentle pressure is applied to the puncture site with a sterile cotton ball or gauze pad to prevent bruising. A small adhesive bandage is then applied.
• Safety and Comfort: The entire venipuncture process takes less than five minutes and is associated with minimal discomfort, similar to a brief pinch. All materials used are sterile and disposed of immediately in accordance with international biosafety standards.

When is a Growth Hormone performed?

Evaluation of Pediatric Growth Failure

Pediatricians and pediatric endocrinologists recommend a growth hormone test when a child exhibits a growth rate that is significantly below the expected percentile for their age and gender. Symptoms such as short stature, delayed physical development, and delayed bone age (as determined by X-ray) are key clinical indications. The test helps differentiate between constitutional growth delay and true growth hormone deficiency, enabling timely intervention with recombinant growth hormone therapy.

Diagnosis of Adult Acromegaly

In adults, excessive secretion of growth hormone, usually caused by a benign pituitary tumor (adenoma), leads to a progressive condition known as acromegaly. Physicians order a growth hormone test, often alongside an oral glucose tolerance test (OGTT) for GH suppression, when an adult patient presents with classic symptoms such as enlargement of the hands, feet, jaw, and facial bones, joint pain, deep voice, and cardiovascular complications.

Assessment of Pituitary Gland Disorders

The growth hormone test is an essential component of a comprehensive pituitary function panel. It is performed when a patient is suspected of having hypopituitarism, which can be caused by pituitary tumors, head trauma, brain surgery, radiation therapy, or autoimmune diseases. Evaluating growth hormone levels helps determine the extent of pituitary damage and guides hormone replacement strategies.

Investigation of Childhood Gigantism

If a child experiences rapid, abnormal, and excessive linear growth before the epiphyseal plates of the long bones have fused, a growth hormone test is urgently performed. This condition, known as pituitary gigantism, is characterized by extreme height and muscle weakness. Early diagnosis through growth hormone measurement is vital to prevent severe skeletal deformities and systemic health issues.

Monitoring of Growth Hormone Replacement Therapy

Patients who have been diagnosed with growth hormone deficiency and are receiving recombinant human growth hormone (rhGH) therapy require regular testing. Monitoring growth hormone and Insulin-like Growth Factor 1 (IGF-1) levels allows endocrinologists to assess the efficacy of the treatment, adjust dosages to therapeutic levels, and minimize the risk of potential side effects associated with over-treatment.

What Does a Growth Hormone Detect?

The Growth Hormone test at Dr. Essa Lab is a highly sensitive diagnostic tool that detects and aids in the evaluation of numerous medical conditions. Specifically, this investigation is utilized to identify:

• Growth Hormone Deficiency (GHD): Inadequate production of somatotropin, leading to short stature in children and altered body composition in adults.
• Adult Growth Hormone Deficiency (AGHD): Characterized by decreased muscle mass, increased central adiposity, fatigue, and impaired quality of life.
• Pituitary Gigantism: Excessive growth hormone secretion in children prior to the fusion of epiphyseal growth plates.
• Acromegaly: Overproduction of growth hormone in adults, leading to somatic overgrowth and systemic complications.
• Somatotroph Adenomas: Benign tumors of the anterior pituitary gland that actively secrete growth hormone.
• Hypopituitarism: Generalized underactivity of the pituitary gland, affecting multiple endocrine axes.
• Sheehan’s Syndrome: Postpartum pituitary necrosis resulting in severe hormone deficiencies, including growth hormone.
• Laron Syndrome: A rare genetic disorder characterized by growth hormone insensitivity despite normal or elevated GH levels.
• Hypothalamic Dysfunction: Impaired regulation of pituitary secretion due to lesions or disorders in the hypothalamus.
• Pituitary Dwarfism: Severe growth retardation in children due to congenital growth hormone deficiency.
• Ectopic GH-producing Tumors: Rare non-pituitary malignancies that secrete growth hormone or GHRH.
• Empty Sella Syndrome: A structural condition where the pituitary gland is flattened or shrunken, potentially affecting hormone output.
• Craniopharyngioma: A benign brain tumor near the pituitary gland that can compress tissue and impair growth hormone secretion.
• Head Trauma-Induced Pituitary Dysfunction: Damage to the pituitary stalk or gland following traumatic brain injury.
• Radiation-Induced Pituitary Damage: Hypofunction of the pituitary gland following cranial radiotherapy for brain tumors.
• Growth Hormone Resistance: Conditions where peripheral tissues fail to respond adequately to circulating growth hormone.
• Constitutional Delay of Growth and Puberty (CDGP): Differentiating temporary developmental delays from permanent endocrine pathology.
• Nutritional Deprivation-Induced GH Elevation: Elevated growth hormone levels as a physiological response to severe malnutrition or anorexia nervosa.
• Chronic Kidney Disease-Associated GH Alterations: Altered clearance and action of growth hormone in patients with renal failure.
• Liver Cirrhosis-Induced GH Resistance: Impaired hepatic production of IGF-1 leading to compensatory elevations in growth hormone.
• Pituitary Apoplexy: Acute hemorrhage or infarction of the pituitary gland, requiring urgent endocrine evaluation.
• Psychosocial Dwarfism: A growth disorder caused by extreme emotional deprivation or abuse, which temporarily suppresses GH secretion.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is dedicated to providing rapid, reliable, and highly accurate diagnostic reporting. The turnaround time for a standard Growth Hormone test is typically within 24 to 48 hours from the time of sample collection. For dynamic stimulation or suppression tests, which involve multiple sequential blood draws, the processing time may vary slightly to ensure meticulous analysis of each specimen. Once the results are finalized and verified by our consultant pathologists, patients receive an automated SMS notification. Reports can be securely accessed, viewed, and downloaded online via the official Dr. Essa Lab web portal or dedicated mobile application. Physical copies of the reports are also available for collection at any of our diagnostic centers across Karachi and other major cities.

Growth Hormone Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Basal Growth Hormone (Adult Male)	< 5.0 ng/mL	Elevated in acromegaly, liver disease, or starvation; decreased in hypopituitarism.
Basal Growth Hormone (Adult Female)	< 10.0 ng/mL	Elevated in pregnancy, estrogen therapy, or acromegaly; decreased in pituitary insufficiency.
Basal Growth Hormone (Children)	0.0 – 20.0 ng/mL	Highly variable; low levels suggest GHD; extremely high levels suggest gigantism.
GH Stimulation Test (Peak Level)	> 10.0 ng/mL (Normal response)	< 5.0 ng/mL indicates severe growth hormone deficiency; 5.0 – 10.0 ng/mL suggests partial deficiency.
GH Suppression Test (Post-Glucose)	Suppression to < 1.0 ng/mL (or < 0.3 ng/mL on sensitive assays)	Failure to suppress indicates autonomous GH secretion, confirming acromegaly.
Insulin-like Growth Factor 1 (IGF-1)	Age and gender-specific normal ranges	Elevated in acromegaly and gigantism; decreased in growth hormone deficiency and malnutrition.
Pituitary Gland Function	Balanced secretion of pituitary hormones	Hypofunction (hypopituitarism) or hyperfunction (pituitary adenoma).
Hypothalamic-Pituitary Axis	Intact feedback regulation	Disrupted feedback loops due to tumors, trauma, or genetic mutations.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Growth Hormone?

• ISO 15189 Certified Laboratories: Dr. Essa Lab maintains the highest international standards of quality and accuracy in diagnostic pathology.
• Highly Qualified Pathologists and Endocrinologists: Our team of experienced specialists ensures precise interpretation of complex endocrine assays.
• Advanced CLIA Technology: We utilize state-of-the-art chemiluminescence immunoassay platforms for superior analytical sensitivity.
• Extensive Branch Network: Conveniently located diagnostic centers across Karachi and other major cities in Pakistan.
• Reliable Home Sample Collection: Professional phlebotomy services delivered directly to your doorstep for maximum convenience.
• Secure Online Report Access: View and download your diagnostic reports anytime through our user-friendly web portal and mobile app.
• Affordable and Transparent Pricing: High-quality diagnostic services offered at competitive rates to ensure accessibility for all patients.
• Legacy of Trust Since 1987: Over three decades of commitment to diagnostic excellence, patient care, and community health.